Cytogel Pharma, LLC

Other Darien, CT

About

Issuer

Entity type
Limited Liability Company
Jurisdiction
Connecticut
Sector
Other
Headquarters
Darien, CT
Street
3 Thorndal Circle
Zip
06820

Offering

Total offering
$16M
Amount sold
$0
First sale
—
Min investment
$50k
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
0

How this filing compares

Ranked #68 of 222 Other filings in March 2026 by offering amount.

Median Other filing in March 2026: $5.4M. This offering is 2.9× the median.

Other Connecticut filings this week: Fremen Capital Onshore Fund LP, M28 Capital Onshore Fund LP, ParaFi Quantitative Strategies International LP, ParaFi Quantitative Strategies LP, TREXQUANT ONSHORE FUND LP

Leadership

C. Dean Maglaris — Executive Officer (also: Director)

Jerry P. Leamon — Director

Cassandra Klimp — Director

Frederick W. Telling — Executive Officer (also: Director)

Steven Chrust — Director

Also named on: Ascellus Health, Inc.

Michael Ullmann — Director

Eric Lang — Director

Theodore Maione — Executive Officer

Filing details

Cytogel Pharma, LLC filed a Form D with the SEC on March 26, 2026.

Other newest Other companies

Other newest companies in Connecticut